Bausch Health Companies (BHC) Cash from Investing Activities (2009 - 2026)

Bausch Health Companies has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$93.0 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 7.0% year-over-year to -$93.0 million; the TTM figure through Jun 2026 stood at -$597.0 million (down 12.22% YoY), while the FY2025 annual figure was -$595.0 million, down 31.06% from the prior year.
• Cash from Investing Activities came in at -$93.0 million for Q2 2026 at Bausch Health Companies, up from -$139.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$30.0 million in Q2 2023 to a low of -$1.9 billion in Q3 2023.
• Average Cash from Investing Activities over 5 years is -$207.2 million, with a median of -$96.5 million recorded in 2025.
• Year-over-year, Cash from Investing Activities tumbled 3464.15% in 2023 and surged 94.6% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$136.0 million in 2022, then dropped by 8.82% to -$148.0 million in 2023, then tumbled by 35.14% to -$200.0 million in 2024, then plunged by 41.0% to -$282.0 million in 2025, then soared by 67.02% to -$93.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$93.0 million in Q2 2026, -$139.0 million in Q1 2026, and -$282.0 million in Q4 2025.